A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
暂无分享,去创建一个
P. Korkolopoulou | E. Patsouris | G. Levidou | A. Saetta | N. Kavantzas | N. Thalassinos | P. Tomos | E. Spartalis | I. Chatziandreou | E. Trigka | N. Anastasiou